# Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease

> **NCT06425120** · PHASE4 · RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 240 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Xuesaitong Soft Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06425120
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06425120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06425120, "Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06425120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*